Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Toshiaki Suguro"'
Autor:
Takuya Watanabe, Takatoshi Koyama, Masayoshi Shichiri, Shigeaki Kimoto, Toshiaki Suguro, Kengo Sato
Publikováno v:
Regulatory Peptides. 162:129-132
Salusin-alpha was recently shown to exert anti-atherosclerotic effects and its potential role as a clinical marker for atherosclerosis has been proposed. We determined serum salusin-alpha concentrations in 99 patients across a diverse range of renal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e8cea8c234ef3698d3b79ebb20bb9b1
https://doi.org/10.1016/j.regpep.2010.03.009
https://doi.org/10.1016/j.regpep.2010.03.009
Autor:
Toshiaki Suguro, Tetsuo Sakai, Shigeki Hongo, Takuya Watanabe, Akira Miyazaki, Shigeko Arita, Yuji Shiraishi
Publikováno v:
Current Medicinal Chemistry. 16:550-563
Human urotensin II (U-II), the most potent vasoconstrictor undecapeptide identified to date, and its receptor (UT) are involved in the pathogenesis of systemic and pulmonary hypertension. Here, we review recent advances in our understanding of the pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6ec99bf45147b855ac36b70437b5ead
https://doi.org/10.2174/092986709787458515
https://doi.org/10.2174/092986709787458515
Autor:
Tsunenori Idei, Nobumasa Kato, Akira Miyazaki, Yoshiyuki Ban, Ryuji Sato, Youichi Kobayashi, Tsutomu Hirano, Taka-aki Matsuyama, Yoshio Ban, Yasuko Nakano, Toshiaki Suguro, Yoshitaka Iso, Tetsuo Sakai, Hidekazu Ota, Takuya Watanabe
Publikováno v:
Journal of Atherosclerosis and Thrombosis. 16:179-187
Aim: Human urotensin-II (UII) is a cyclic neuropeptide with potent vasoconstrictive activity in the vasculature. The expression of UII and its receptor (UT) mRNA is detected at high levels in the brain. We evaluated the relationship between plasma UI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f538afeb4ad9bd181367d82235f6ca8
https://doi.org/10.5551/jat.e608
https://doi.org/10.5551/jat.e608
Autor:
Tsutomu Hirano, Toshiaki Suguro, Takuya Watanabe, Mitsuru Adachi, Akira Miyazaki, Gang Xu, Syuusuke Kodate
Publikováno v:
Clinical Science. 115:327-334
Human U-II (urotensin-II), the most potent vasoconstrictor peptide identified to date, is associated with cardiovascular disease. A single nucleotide polymorphism (S89N) in the gene encoding U-II (UTS2) is associated with the onset of Type 2 diabetes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ade7cba63966621c60d4770ee9b36e7e
https://doi.org/10.1042/cs20080014
https://doi.org/10.1042/cs20080014
Autor:
Mitsuru Adachi, Takuya Watanabe, Masaharu Nagashima, Yuji Shiraishi, Hiroyuki Itabe, Rina Kato, Shigeki Hongo, Akira Miyazaki, Tsutomu Hirano, Toshiaki Suguro
Publikováno v:
Journal of Hypertension. 26:1955-1965
Objective Our recent studies have indicated that urotensin II, the most potent vasoconstrictor peptide identified to date, potentiates human macrophage foam cell formation and vascular smooth muscle cell proliferation, and its levels are increased in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e2dac001d340278a310ada2cc17e48a
https://doi.org/10.1097/hjh.0b013e32830b61d8
https://doi.org/10.1097/hjh.0b013e32830b61d8
Autor:
Akira Miyazaki, Syuusuke Kodate, Masayoshi Shichiri, Tsutomu Hirano, Kengo Sato, Mitsuru Adachi, Toshiaki Suguro, Takuya Watanabe, Takatoshi Koyama, Masaharu Nagashima
Publikováno v:
Hypertension Research. 31:463-468
Salusin-alpha is a new bioactive peptide with mild hypotensive and bradycardic effects. Our recent study showed that salusin-alpha suppresses foam cell formation in human monocyte-derived macrophages by down-regulating acyl-CoA:cholesterol acyltransf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d04ffd0213dbe88653cbca91cebae93
https://doi.org/10.1291/hypres.31.463
https://doi.org/10.1291/hypres.31.463
Autor:
Takuya Watanabe, Akira Miyazaki, Tomoko Kanome, Syuusuke Kodate, Mitsuru Adachi, Tsutomu Hirano, Toshiaki Suguro
Publikováno v:
Atherosclerosis. 186:275-281
Acyl-coenzyme A:cholesterol acyltransferase-1 (ACAT-1) converts intracellular free cholesterol into cholesterol ester for storage in lipid droplets and plays an important role in the formation of macrophage-derived foam cells in atherosclerotic lesio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6172b43354ea2d9a89bdcc96815ff27
https://doi.org/10.1016/j.atherosclerosis.2005.08.007
https://doi.org/10.1016/j.atherosclerosis.2005.08.007
Publikováno v:
Vascular Disease Prevention. 3:91-98
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf9c5568e52677b8386763a5381ba2e8
https://doi.org/10.2174/156727006776819396
https://doi.org/10.2174/156727006776819396
Autor:
Syuusuke Kodate, Toshiaki Suguro, Tamio Hagiwara, Akira Miyazaki, Tomoko Kanome, Shigeki Hongo, Mitsuru Adachi, Yu-Ichiro Sakamoto, Takuya Watanabe, Tsutomu Hirano
Publikováno v:
Hypertension. 46:738-744
Human urotensin II (U-II), the most potent vasoconstrictor peptide identified to date, and its receptor (UT) are involved in hypertension and atherosclerosis. Acyl-coenzyme A:cholesterol acyltransferase-1 (ACAT-1) converts intracellular free choleste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4afd8a50bea75eca0de98a989968fdd
https://doi.org/10.1161/01.hyp.0000184226.99196.b5
https://doi.org/10.1161/01.hyp.0000184226.99196.b5
Publikováno v:
Rinsho byori. The Japanese journal of clinical pathology. 54(6)
Small dense low-density lipoprotein (sd LDL) is more atherogenic than large buoyant (lb) LDL, which is relatively high in particle number (as estimated by apolipoprotein [apo] B) and poor in cholesterol (C) content. Because recent epidemiological stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::01a5e143e6c03346288f3d7df581864b
https://pubmed.ncbi.nlm.nih.gov/16872005
https://pubmed.ncbi.nlm.nih.gov/16872005